WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its third quarter 2006 financial results after the U.S. Financial Markets close on Thursday, October 26, 2006. Following the announcement, Panacos will hold a conference call to discuss the results and provide an update on the Company’s development programs. Peyton J. Marshall, CFO and Acting CEO, and Graham P. Allaway, Ph.D., President and COO will host the call.
